Monoamine Oxidase and Succinate Dehydrogenase Inhibitory and Anticonvulsant Activities of Some 3-(N-Arylcarboxamidomethyl)-4-quinazolones
3-(N-Arylcarboxamidomethyl)-4-quinazolones (IIIa-k), prepared from N-aryl-2-chloroacetamides (IIa-k) and 4-quinazolones (I), possess ALD50 values from 500-1000 mg/kg and found to inhibit rat brain monoamine oxidase (MAO) (30-65percent) and succinate dehydrogenase (SDH) (10-80percent) in vitro at a concentration of 5*10-4 M and provide 30-50percent protection against pentylenetetrazole-induced convulsions in mice.
Saksena, R. K.,Yasmeen, Rana
p. 438 - 440
(2007/10/02)
More Articles about upstream products of 108086-41-5
